Biotech

All Articles

Arch shuts $3B-plus fund to encourage biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Life Sciences, Arch Project Allies is ...

Orion to make use of Aitia's 'digital identical twins' to find new cancer cells medicines

.Finnish biotech Orion has snooped possible in Aitia's "digital identical twin" technology to build ...

Windtree's shock med increases blood pressure in latest phase 2 win

.While Windtree Therapeutics has had a hard time to increase the financial origins needed to make it...

2 cancer cells biotechs combine, making global impact

.OncoC4 is actually taking AcroImmune-- and its own internal professional manufacturing functionalit...

Amgen reports first period 3 gain for $400M eczema medicine

.Amgen has shared (PDF) the first phase 3 records on its $400 thousand dermatitis drug, connecting t...

Biogen, UCB record stage 3 lupus gain after neglecting earlier test

.Biogen as well as UCB's rely on improving in to stage 3 on the back of a failed research tries to h...

Aptadir hopes new RNA inhibitors can turn around tricky cancers

.Italian biotech Aptadir Therapeutics has actually released with the promise that its own pipeline o...

Wave surfs DMD effectiveness to regulators' doors, sending stockpile

.Wave Lifestyle Sciences has actually fulfilled its own target in a Duchenne muscular dystrophy (DMD...

Sanofi picks new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, using ...

Achilles drops cell treatment system, prepares for layoffs after overlooking 'industrial stability' objectives

.Achilles Therapeutics has actually wrecked its technique. The English biotech is actually quiting w...